We also showed that normal CD4+ T cells constructed with B65-targeted TCRs exhibit functional reactivity against SARS-CoV-2 S. Our study provided valuable information for developing potential vaccines and new treatment strategies against COVID-19. Here, CD4 is linked to COVID-19.